Answers are grounded in this paper and cite their sources.
PI3K/AKT pathway aberrations are present in 18% of pediatric T-cell acute lymphoblastic leukemia patients. Absence of strong NOTCH1-activating mutations in these cases may explain cellular insensitivity to γ-secretase inhibitors.
No takes yet. Share an insight, caveat, or question.
Zuurbier et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: